Mpox

Below is an overview of various sections of The Swedish COVID-19 & Pandemic Preparedness Portal where information about research data and resources relevant to Mpox can be found. For a short background on this topic below, see the description below.

Open funding opportunities (5)

Call title	Deadline	Funder	Topics
Grant for research time in a clinical environment The purpose of the grant is to give clinically active persons the opportunity to carry out research on a part-time basis in parallel with developing their clinical competence. The aim is to … Grant for research time in a clinical environment Funder: Swedish Research Council Submission opens: February 22, 2023 Submission deadline: March 28, 2023 Funding amount: A standard amount based on the activity level (1 510 000 SEK per year, 1 680 000 SEK per year, or 1 850 000 SEK per year). Funding period: 2-6 years starting Jan 2024. Eligible applicant: Individual researcher who completed a doctoral degree no more than 10 years ago. Decision date: No later than the beginning of October 2023. Call description: The purpose of the grant is to give clinically active persons the opportunity to carry out research on a part-time basis in parallel with developing their clinical competence. The aim is to reinforce and renew medical and clinical research. See call website for more information	March 28, 2023	Swedish Research Council	General
Project grant for research into viruses and pandemics – from fundamental mechanisms to medical interventions The purpose of the project grant is to give researchers the freedom to formulate their own research idea, method and implementation, and to solve a specific research task within a limited … Project grant for research into viruses and pandemics – from fundamental mechanisms to medical interventions Funder: Swedish Research Council Submission opens: February 22, 2023 Submission deadline: March 28, 2023 Funding amount: Minimum 400 000 SEK per year, maximum 2 500 000 SEK per year. Funding period: 1-3 years starting Jan 2024. Eligible applicant: Individual researcher and up to 6 other researchers may be invited to join the application Decision date: No later than the beginning of November 2023. Call description: The purpose of the project grant is to give researchers the freedom to formulate their own research idea, method and implementation, and to solve a specific research task within a limited period. The focus of this call is on research into basic virology and fundamental disease mechanisms caused by viruses. It also covers research into areas such as zoonoses, the development of medicines, vaccines, diagnostics and treatments. The initiative is part of the national research programme in viruses and pandemics. See call website for more information	March 28, 2023	Swedish Research Council	Infectious diseasesGeneral
Respiratory Pathogens Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe's services, falls under topics defined in the Scope (see funding link for details), … Respiratory Pathogens Funder: ISIDORe Submission opens: November 1, 2022 Submission deadline: January 1, 2025 Funding amount: Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount. Call description: Researchers are invited to submit any proposal that can be advanced by access to at least one of ISIDORe’s services, falls under topics defined in the Scope (see funding link for details), and/or is focused on at least one eligible respiratory pathogen (see funding link for details). Your proposal must focus on at least one of the following pathogens: Zoonotic betacoronaviruses, Influenza A, Yersinia pestis, Mycobacterium tuberculosis/bovis, Coxiella burnetii. See call website for more information	January 1, 2025	ISIDORe	Infectious diseasesGeneral

See all open funding opportunities on Mpox (5)

This page is under development, with more resources being added shortly. In the meantime, check out the mpox page in our 'emerging pathogens' section. That page contains more extensive information and useful links to other related resources.

For a fuller overview, refer to the mpox page of our emerging pathogens section.

Background

Mpox a.k.a. Monkeypox is caused by the mpox virus, and is a zoonotic disease (i.e. it is transmitted from animals to humans). The mpox virus is a member of the Orthopoxvirus genus in the family Poxviridae. It is closely related to the variola virus, which causes smallpox and has had a marked impact on human populations throughout history. According to WHO there are currently two clades of mpox virus; the West African clade and the Congo Basin (Central African) clade. An outbreak began in Europe during May 2022. As of Septmber 2022, more than 20,000 cases have been detected in Europe, with 161 cases detected in Sweden and reported to the Swedish Public Health Agency.

Clinically, mpox is typically characterised by fever, an unexplained acute rash, and lymphadenopathy. Additional symptoms and complications may also occur, though. For more information about the clinical symptoms of mpox, see information from the CDC. The incubation period of the virus is typically 5-13 days, but can be as long as three weeks. Close personal contact with an infected individual is currently (September, 2022) the most common way of transmission and limited information is available regarding mortality (Adler et al., 2022). The European Medicines Agency has not yet approved a vaccine in Europe. However, EU healthcare has access to doses of Jynneos vaccine, which is approved by the FDA for both mpox and smallpox. These vaccine doses were donated by the USA and Canada via the European Health Emergency Preparedness and Response Authority (HERA).

There are no approved treatments for human mpox as of September 2022. However, brincidofovir and tecovirimat, which are both drugs approved in the USA for use against smallpox, have been repurposed and show promise in animal studies (Adler et al., 2022).

Open funding opportunities (5)

Grant for research time in a clinical environment

Project grant for research into viruses and pandemics – from fundamental mechanisms to medical interventions

Respiratory Pathogens

Background